Phenotypic Severity Determines Overall Pregnancy Outcome and Survival in Fetuses With Turner Syndrome: Insights From a Large Multicenter Cohort

OBJECTIVE: To evaluate survival in fetuses with prenatally diagnosed Turner syndrome (TS) according to karyotype and phenotypic severity, and to estimate minimal survival (MS) proportions across cytogenetic subgroups. METHODS: Retrospective multicentre cohort study including fetuses with prenatal TS diagnosed between 2000 and 2024. Karyotypes were classified as 45,X; mosaic; or structural X-chromosome anomalies. Phenotypic severity was defined by major structural abnormalities on prenatal imaging. Survival analyses and Cox proportional hazard models were applied. MS was calculated as the proportion of Live births (LB) relative to elective terminations (ET) and Spontaneous intrauterine deaths (SID) within each karyotype group. RESULTS: Among 726 pregnancies, 451 (62.1%) were ET, 275 (37.9%) continued; of these, 98 (35.6%) resulted in LB and 177 (64.4%) in SID. Severe phenotypes were present in 92.4% of terminations, 81.0% of SIDs and 33.0% of LB. Mosaic and structural karyotypes showed a lower risk of intrauterine death than 45,X (HR 0.28 and 0.32), while severe phenotype strongly predicted mortality (HR 4.82). Most SIDs occurred before 30 weeks' gestation (median 21 weeks). MS was 9.6% for 45,X, 50.0% for mosaic and 36.8% for structural variants. CONCLUSION: Survival in prenatally diagnosed TS is higher than historically reported. Phenotypic severity is the principal determinant of outcome.

Authors

Institutions

Publication Details

Journal
Prenatal Diagnosis
Published
2026-11-18
DOI
https://doi.org/10.1002/pd.70302
Primary Topic
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Phenotypic Severity Determines Overall Pregnancy Outcome and Survival in Fetuses With Turner Syndrome: Insights From a Large Multicenter Cohort

Johanna Bruder, Anne H Skakkebaek, Anita Windhorst, Claus Højbjerg Gravholt et al.
Prenatal Diagnosis
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
article

Phenotypic Severity Determines Overall Pregnancy Outcome and Survival in Fetuses With Turner Syndrome: Insights From a Large Multicenter Cohort

Johanna Bruder, Anne H Skakkebaek, Anita Windhorst, Claus Højbjerg Gravholt, R Axt-Fliedner, Ivonne Alexandra Bedei
article en

Abstract

OBJECTIVE: To evaluate survival in fetuses with prenatally diagnosed Turner syndrome (TS) according to karyotype and phenotypic severity, and to estimate minimal survival (MS) proportions across cytogenetic subgroups. METHODS: Retrospective multicentre cohort study including fetuses with prenatal TS diagnosed between 2000 and 2024. Karyotypes were classified as 45,X; mosaic; or structural X-chromosome anomalies. Phenotypic severity was defined by major structural abnormalities on prenatal imaging. Survival analyses and Cox proportional hazard models were applied. MS was calculated as the proportion of Live births (LB) relative to elective terminations (ET) and Spontaneous intrauterine deaths (SID) within each karyotype group. RESULTS: Among 726 pregnancies, 451 (62.1%) were ET, 275 (37.9%) continued; of these, 98 (35.6%) resulted in LB and 177 (64.4%) in SID. Severe phenotypes were present in 92.4% of terminations, 81.0% of SIDs and 33.0% of LB. Mosaic and structural karyotypes showed a lower risk of intrauterine death than 45,X (HR 0.28 and 0.32), while severe phenotype strongly predicted mortality (HR 4.82). Most SIDs occurred before 30 weeks' gestation (median 21 weeks). MS was 9.6% for 45,X, 50.0% for mosaic and 36.8% for structural variants. CONCLUSION: Survival in prenatally diagnosed TS is higher than historically reported. Phenotypic severity is the principal determinant of outcome.

Prenatal Diagnosis
Justus-Liebig-Universität Gießen (DE), Aarhus University (DK), Aarhus University Hospital (DK)
Novo Nordisk, Universität zu Köln, Novo Nordisk Fonden, Universitätsklinikum Heidelberg
Good health and well-being
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon